Skip to main content
Caplight Logo









Diagnoptics Technologies

Diagnoptics Technologies

Private
GroningenHealthcare & Life Scienceshttps://diagnoptics.com

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Diagnoptics Technologies operates in Healthcare & Life Sciences and is based in Groningen. It was founded in 2003.

Diagnoptics Technologies is a medical technology company that develops non-invasive diagnostic devices for assessing cardiovascular risk and diabetes complications by measuring Advanced Glycation Endproducts (AGEs).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Diagnoptics Technologies Comparables

Compare Diagnoptics Technologies with similar companies based on industry and business-model similarity.

No comparables are published for Diagnoptics Technologies. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Diagnoptics Technologies Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Diagnoptics Technologies. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

John Mulder

CEO

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 301% MoM, reaching 1K.

  • Jun 15, 2026

    Grew 50% QoQ, from 6 to 9 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Diagnoptics Technologies Filings

Explore SEC and related filing metadata, where available.

Diagnoptics Technologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Diagnoptics Technologies's valuation, stock price, and market status.

Is Diagnoptics Technologies a public or private company?

Diagnoptics Technologies is a private company.

What is the current stock price of Diagnoptics Technologies?

Diagnoptics Technologies is a private company, so its shares have no public market price. Caplight tracks Diagnoptics Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Diagnoptics Technologies worth (valuation)?

Valuation information for Diagnoptics Technologies is not publicly available.

Can I buy Diagnoptics Technologies stock?

Diagnoptics Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Diagnoptics Technologies's last funding round?

Funding round information for Diagnoptics Technologies is not publicly available.

Who are the main investors in Diagnoptics Technologies?

Investor information for Diagnoptics Technologies is not publicly disclosed.

Will Diagnoptics Technologies IPO soon?

No public IPO plans have been announced for Diagnoptics Technologies.

How can I track Diagnoptics Technologies secondary market activity?

Caplight tracks bids, offers, and trades in Diagnoptics Technologies's shares on secondary markets.

Firmographic Details

HeadquartersGroningen
Employee Range9
Year Founded2003
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?